| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1257-1266, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
DM Mann, T Iwatsubo, Y Ihara, NJ Cairns, PL Lantos, N Bogdanovic, L Lannfelt, B Winblad, ML Maat-Schieman and MN Rossor
Department of Pathological Sciences, University of Manchester, United Kingdom.
Amyloid (A beta) deposition was investigated in cases of Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis, Dutch type, due to mutations in the amyloid precursor protein (APP) gene using the end-specific monoclonal antibodies BA27 and BC05 that recognize A beta 40 or A beta 42(43), respectively. In cases of APP717 mutation the predominant A beta species within plaques terminate at A beta 42(43) with relatively little A beta 40 being present. The total amount of A beta deposited as A beta 42(43) is significantly greater than in sporadic Alzheimer's disease, consistent with the suggestion that this mutation might influence the processing of APP so as to produce more of the highly aggregatable form, A beta 1-42. In cases of APP670/671 mutation the major peptide in plaques is also A beta 42(43), although the proportion of plaques containing A beta 40, and the total A beta load is similar to that in sporadic Alzheimer's disease. As in sporadic Alzheimer's disease, the vascular amyloid in APP670/671 and APP717 and in cases of hereditary cerebral hemorrhage with amyloidosis, Dutch type is predominantly A beta 40 in this latter disorder, however, parenchymal deposits are exclusively A beta 42(43). Although the various APP mutations may influence the type, quantity, and location of A beta deposited, the predominant, and possibly the initial, species deposited in the brain parenchyma is A beta 42(43).
This article has been cited by other articles:
 |
|
 |
|
  M. Ingelsson, H. Fukumoto, K. L. Newell, J. H. Growdon, E. T. Hedley-Whyte, M. P. Frosch, M. S. Albert, B. T. Hyman, and M. C. Irizarry Early A{beta} accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain Neurology, March 23, 2004; 62(6): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Stanton and R. H. Coetzee Down's syndrome and dementia Advan. Psychiatr. Treat., January 1, 2004; 10(1): 50 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xia and M. S. Wolfe Intramembrane proteolysis by presenilin and presenilin-like proteases J. Cell Sci., July 15, 2003; 116(14): 2839 - 2844. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Guillozet, S. Weintraub, D. C. Mash, and M. M. Mesulam Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment Arch Neurol, May 1, 2003; 60(5): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kumar-Singh, P. Cras, R. Wang, J. M. Kros, J. van Swieten, U. Lubke, C. Ceuterick, S. Serneels, K.'l Vennekens, J.-P. Timmermans, et al. Dense-Core Senile Plaques in the Flemish Variant of Alzheimer's Disease Are Vasocentric Am. J. Pathol., August 1, 2002; 161(2): 507 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. SCHUPF and G. H. Sergievsky Genetic and host factors for dementia in Down's syndrome The British Journal of Psychiatry, May 1, 2002; 180(5): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hashimoto, T. Niikura, Y. Ito, H. Sudo, M. Hata, E. Arakawa, Y. Abe, Y. Kita, and I. Nishimoto Detailed Characterization of Neuroprotection by a Rescue Factor Humanin against Various Alzheimer's Disease-Relevant Insults J. Neurosci., December 1, 2001; 21(23): 9235 - 9245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Parvathy, P. Davies, V. Haroutunian, D. P. Purohit, K. L. Davis, R. C. Mohs, H. Park, T. M. Moran, J. Y. Chan, and J. D. Buxbaum Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline Arch Neurol, December 1, 2001; 58(12): 2025 - 2031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. A. Mann, S. M. Pickering-Brown, A. Takeuchi, and T. Iwatsubo Amyloid Angiopathy and Variability in Amyloid {beta} Deposition Is Determined by Mutation Position in Presenilin-1-Linked Alzheimer's Disease Am. J. Pathol., June 1, 2001; 158(6): 2165 - 2175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kumar-Singh, C. De Jonghe, M. Cruts, R. Kleinert, R. Wang, M. Mercken, B. De Strooper, H. Vanderstichele, A. Lofgren, I. Vanderhoeven, et al. Nonfibrillar diffuse amyloid deposition due to a {gamma}42-secretase site mutation points to an essential role for N-truncated A{beta}42 in Alzheimer's disease Hum. Mol. Genet., November 1, 2000; 9(18): 2589 - 2598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss Am. J. Pathol., July 1, 2000; 157(1): 331 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Janssen, M. Hall, N. C. Fox, R. J. Harvey, J. Beck, A. Dickinson, T. Campbell, J. Collinge, P. L. Lantos, L. Cipolotti, et al. Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation: A clinicopathological study Brain, May 1, 2000; 123(5): 894 - 907. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. GREENBERG, H.-S. CHO, H. C. O'DONNELL, J. ROSAND, A. Z. SEGAL, L. H. YOUNKIN, S. G. YOUNKIN, and G. W. REBECK Plasma {beta}-Amyloid Peptide, Transforming Growth Factor-{beta}1, and Risk for Cerebral Amyloid Angiopathy Ann. N.Y. Acad. Sci., April 1, 2000; 903(1): 144 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Lippa, K. Ozawa, D. M. A. Mann, K. Ishii, T. W. Smith, S. Arawaka, and H. Mori Deposition of {beta}-Amyloid Subtypes 40 and 42 Differentiates Dementia With Lewy Bodies From Alzheimer Disease Arch Neurol, September 1, 1999; 56(9): 1111 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q.-X. Li, R. Cappai, G. Evin, J. E. Tanner, C. W. Gray, K. Beyreuther, and C. L. Masters Products of the Alzheimer's disease amyloid precursor protein generated by,{beta}-secretase are present in human platelets, and secreted upon degranulation American Journal of Alzheimer's Disease and Other Dementias, September 1, 1998; 13(5): 236 - 244. [Abstract] [PDF]
|
|
|
|
 |
|
 C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. E. Bacarra, D. M. Romano, M. A. Hartshorn, R. E. Tanzi, and A. I. Bush Dramatic Aggregation of Alzheimer Abeta by Cu(II) Is Induced by Conditions Representing Physiological Acidosis J. Biol. Chem., May 22, 1998; 273(21): 12817 - 12826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xia, J. Zhang, D. Kholodenko, M. Citron, M. B. Podlisny, D. B. Teplow, C. Haass, P. Seubert, E. H. Koo, and D. J. Selkoe Enhanced Production and Oligomerization of the 42-residue Amyloid beta -Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins J. Biol. Chem., March 21, 1997; 272(12): 7977 - 7982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lalowski, A. Golabek, C. A. Lemere, D. J. Selkoe, H. M. Wisniewski, R. C. Beavis, B. Frangione, and T. Wisniewski The "Nonamyloidogenic" p3 Fragment (Amyloid beta 17-42) Is a Major Constituent of Down's Syndrome Cerebellar Preamyloid J. Biol. Chem., December 27, 1996; 271(52): 33623 - 33631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Castano, F. Prelli, C. Soto, R. Beavis, E. Matsubara, M. Shoji, and B. Frangione The length of Amyloid-beta in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type. IMPLICATIONS FOR THE ROLE OF AMYLOID-beta 1-42 IN ALZHEIMER'S DISEASE J. Biol. Chem., December 13, 1996; 271(50): 32185 - 32191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Citron, T. S. Diehl, G. Gordon, A. L. Biere, P. Seubert, and D. J. Selkoe Evidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta -amyloid precursor protein by different protease activities PNAS, November 12, 1996; 93(23): 13170 - 13175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Selkoe and D. J. Selkoe Amyloid beta -Protein and the Genetics of Alzheimer's Disease J. Biol. Chem., August 2, 1996; 271(31): 18295 - 18298. [Full Text] [PDF]
|
|
|
|
|
|
H. Steiner, T. Revesz, M. Neumann, H. Romig, M. G. Grim, B. Pesold, H. A. Kretzschmar, J. Hardy, J. L. Holton, R. Baumeister, et al. A Pathogenic Presenilin-1 Deletion Causes Abberrant Abeta 42 Production in the Absence of Congophilic Amyloid Plaques J. Biol. Chem., March 2, 2001; 276(10): 7233 - 7239. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
